Global specialty pipeline accelerates growth
Nearly one in five women worldwide are now living with obesity
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
We are building an AI-native operating system for pharma sales and distribution
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Subscribe To Our Newsletter & Stay Updated